Yue Yu

3.3k total citations
110 papers, 1.7k citations indexed

About

Yue Yu is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yue Yu has authored 110 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Surgery, 34 papers in Oncology and 29 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yue Yu's work include Cancer Immunotherapy and Biomarkers (15 papers), Liver physiology and pathology (10 papers) and Immunotherapy and Immune Responses (9 papers). Yue Yu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (15 papers), Liver physiology and pathology (10 papers) and Immunotherapy and Immune Responses (9 papers). Yue Yu collaborates with scholars based in China, United States and Singapore. Yue Yu's co-authors include Xuehao Wang, Guoqiang Li, Jie He, Liyong Pu, Xiangcheng Li, Aihua Yao, Beicheng Sun, Donglin Zhu, Jingping Shi and Yueqiu Chen and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yue Yu

106 papers receiving 1.7k citations

Peers

Yue Yu

ONCOL

SURGE

IMMUN

Liuqin Liang China

Hanshi Xu China

Guoyue Lv China

Catriona McKenzie Australia

Wey‐Ran Lin Taiwan

Yiming Zhao China

Jianhua Wang China

María Clorinda Mazzarino Italy

Xingbin Hu China

Chul‐Soo Cho South Korea

Liuqin Liang China

Yue Yu

885 ×1.5

313 ×0.8

ONCOL

157 ×0.5

SURGE

329 ×1.0

496 ×1.6

IMMUN

Citations per year, relative to Yue Yu Yue Yu (= 1×) peers Liuqin Liang

Countries citing papers authored by Yue Yu

Since Specialization

Citations

This map shows the geographic impact of Yue Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yue Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yue Yu more than expected).

Fields of papers citing papers by Yue Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yue Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yue Yu. The network helps show where Yue Yu may publish in the future.

Co-authorship network of co-authors of Yue Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yue Yu. A scholar is included among the top collaborators of Yue Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yue Yu. Yue Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Xiaoli, Dong-Min Shi, Yuxiao Wu, et al.. (2024). Cuproptosis-associated genes (CAGs) contribute to the prognosis prediction and potential therapeutic targets in hepatocellular carcinoma. Cellular Signalling. 117. 111072–111072. 3 indexed citations

Gao, Zhen, Xiao Li, Lin Xu, et al.. (2024). Preoperative markers for identifying CT ≤2 cm solid nodules of lung adenocarcinoma based on image deep learning. Thoracic Cancer. 15(31). 2272–2282. 2 indexed citations

Qiao, Lei, Zibo Xu, Wei‐Wen Chen, et al.. (2024). Integrated analysis of single-cell and bulk RNA sequencing data reveals a cellular senescence-related signature in hepatocellular carcinoma. Frontiers in Cell and Developmental Biology. 12. 1407428–1407428. 1 indexed citations

Yu, Yue, Lu Wu, Dong Ma, et al.. (2024). A multidimensional analysis of the impact of obesity on immune checkpoint inhibitor therapy efficacy. Cancer Cell International. 24(1). 358–358. 2 indexed citations

Yu, Yue, Yujun Chen, Xiaochen Zhou, et al.. (2024). Comparison of novel flexible and traditional ureteral access sheath in retrograde intrarenal surgery. World Journal of Urology. 42(1). 7–7. 24 indexed citations

Zhang, Pengpeng, et al.. (2023). A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer. Frontiers in Immunology. 14. 1199040–1199040. 30 indexed citations

Jiang, Ning, Yue Yu, Dawei Wu, et al.. (2023). HLA and tumour immunology: immune escape, immunotherapy and immune-related adverse events. Journal of Cancer Research and Clinical Oncology. 149(2). 737–747. 19 indexed citations

Li, Qifan, et al.. (2023). Preoperative systemic immune‐inflammation index for predicting the prognosis of thymoma with radical resection. Thoracic Cancer. 14(13). 1192–1200. 6 indexed citations

Sun, Wei, et al.. (2023). Systemic immune-inflammation index predicts survival in patients with resected lung invasive mucinous adenocarcinoma. Translational Oncology. 40. 101865–101865. 16 indexed citations

10.

Chen, Han, Rui Wang, Yue Yu, et al.. (2023). Deubiquitinase OTUB1 regulates doxorubicin-induced cardiotoxicity via deubiquitinating c-MYC. Cellular Signalling. 113. 110937–110937. 12 indexed citations

11.

Fan, Shilong, Yirui Wang, Ruixiang Chen, et al.. (2023). ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma. BMC Cancer. 23(1). 444–444. 10 indexed citations

12.

Tang, Xinyi, Zhi-Zhang Yang, Hyo Jin Kim, et al.. (2022). Phenotype, Function, and Clinical Significance of CD26+ and CD161+Tregs in Splenic Marginal Zone Lymphoma. Clinical Cancer Research. 28(19). 4322–4335. 4 indexed citations

13.

Yu, Yue, Jie Ma, Yingda Zang, et al.. (2022). Meroterpenoids with unknown skeletons from the leaves of Psidium guajava including one anti-inflammatory and anticoagulant compound: psidial F. Fitoterapia. 159. 105198–105198. 6 indexed citations

14.

Li, Xiaoqiang, Hongguang Sun, Xiaohong Wang, et al.. (2022). Activation of C3 and C5 May Be Involved in the Inflammatory Progression of PCM and GM. Inflammation. 45(2). 739–752. 13 indexed citations

15.

Shen, Xian, Wenyan Fu, Yongpeng Wei, et al.. (2021). TIGIT-Fc Promotes Antitumor Immunity. Cancer Immunology Research. 9(9). 1088–1097. 10 indexed citations

16.

Yang, Renjie, et al.. (2021). MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs. International Journal of Biological Sciences. 18(1). 43–64. 18 indexed citations

17.

Yu, Yue, Eric M. Moult, Siyu Chen, et al.. (2020). Developing a potential retinal OCT biomarker for local growth of geographic atrophy. Biomedical Optics Express. 11(9). 5181–5181. 8 indexed citations

18.

Chen, Yunfei, Jiali Jin, Yi Luan, et al.. (2017). p38 inhibition provides anti–DNA virus immunity by regulation of USP21 phosphorylation and STING activation. The Journal of Experimental Medicine. 214(4). 991–1010. 85 indexed citations

19.

Yu, Yue & Jie He. (2013). Molecular classification of non-small-cell lung cancer: diagnosis, individualized treatment, and prognosis. Frontiers of Medicine. 7(2). 157–171. 31 indexed citations

20.

Yu, Yue. (2002). Experimental study of partial orthotopic liver transplantation in rats. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact